GO:0035334 Notch receptor processing, ligand-independent: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035334 describes the proteolytic cleavages of the Notch receptor that occur before ligand binding, including the S1 cleavage in the secretory pathway that generates a heterodimeric receptor transported to the cell surface.
• Ligand-independent Notch processing is distinct from canonical ligand-activated Notch signaling and can drive downstream transcriptional programs in the absence of DSL ligands.
• Key proteases include furin-like convertases for S1 cleavage, and ADAM/TACE and gamma-secretase components for subsequent processing events.
• Ligand-independent Notch activity is modulated by cis-interactions with Notch ligands, endocytic trafficking, and O-glycosylation of the Notch extracellular domain.
• Dysregulated ligand-independent Notch processing has been implicated in atherosclerosis, cancer, and T-cell biology.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise interrogation of genes controlling ligand-independent Notch processing.
Description
Notch receptor processing, ligand-independent (GO:0035334) is a biological process that encompasses the proteolytic cleavages of the Notch protein that occur prior to ligand binding. This process is essential for the maturation and cell-surface presentation of Notch receptors, and it represents a critical step that can influence both canonical ligand-dependent signaling and non-canonical, ligand-independent Notch activity. Researchers studying Notch biology need to understand this term because it defines the molecular events that set the stage for all subsequent Notch signaling, and because dysregulation of these early processing steps has been linked to human diseases including cancer and atherosclerosis. The term is particularly relevant for those investigating how Notch can be activated in the absence of traditional DSL ligands, a phenomenon observed in T-cells and endothelial cells.
Notch receptor processing, ligand-independent At A Glance
| GO ID | GO:0035334 |
|---|---|
| GO term | Notch receptor processing, ligand-independent |
| Ontology | biological_process |
| Synonym | Notch S1 cleavage |
| Definition | The proteolytic cleavages to the Notch protein that occur prior to ligand binding. A primary cleavage event within the extracellular domain whilst the Notch protein in still in the secretory pathway, leads to the transportation of a processed heterodimer to the cell surface. |
| Major function | Maturation and cell-surface presentation of Notch receptors; enables ligand-independent Notch activity |
| Related processes | Notch signaling pathway, protein maturation, secretory pathway trafficking |
| Cellular location | Secretory pathway (ER/Golgi) and cell surface |
What Is GO:0035334?
GO:0035334 refers to the series of proteolytic cleavages that act on the Notch receptor before it binds to a ligand. The primary cleavage event, known as S1 cleavage, occurs within the extracellular domain while the Notch protein is still in the secretory pathway. This cleavage generates a processed heterodimer that is then transported to the cell surface. The term specifically covers the ligand-independent processing steps, distinguishing them from the ligand-induced cleavages that occur later at the plasma membrane.
Why Is Notch receptor processing, ligand-independent Important in Cell Biology?
Understanding GO:0035334 is crucial because ligand-independent Notch processing can influence a wide range of physiological and pathological processes, from T-cell development to endothelial senescence and cancer progression. The S1 cleavage event is a prerequisite for the formation of the mature Notch heterodimer, and its dysregulation can lead to aberrant Notch activation even in the absence of ligands. This has significant implications for therapeutic targeting of Notch in diseases where ligand-independent activation drives pathogenesis.
• Defines the initial proteolytic step required for Notch receptor maturation and surface expression.
• Provides a mechanism for ligand-independent Notch activation, which can occur in T-cells and endothelial cells.
• Implicated in atherosclerosis through cathepsin L-mediated ligand-independent Notch1 activation.
• Relevant to cancer biology, as Notch O-glycosylation and processing influence tumorigenesis.
• Modulated by cis-interactions between Notch and its ligands, which can block ligand-independent activity.
• Involves endocytic trafficking pathways that regulate Notch receptor availability.
• Can be activated by Kuzbanian and TACE independently of ligand in Drosophila.
• Repressed by Ral GTPase-mediated asymmetric Notch activation in the Drosophila eye.
• Serves as a target for CRISPR-based functional studies of Notch pathway genes.
• Potential therapeutic target for diseases driven by aberrant Notch signaling.
What Happens During Notch receptor processing, ligand-independent?
S1 cleavage in the secretory pathway
In simple terms: The Notch protein is cut once inside the cell before it reaches the surface.
The primary cleavage event, known as S1 cleavage, occurs within the extracellular domain of Notch while the protein is still in the secretory pathway. This cleavage is mediated by furin-like convertases and generates two fragments that remain associated as a heterodimer. The S1 cleavage is a prerequisite for the transport of the processed heterodimer to the cell surface. This step is ligand-independent and represents the defining event of GO:0035334.
Formation and trafficking of the Notch heterodimer
In simple terms: After being cut, the two pieces of Notch stick together and travel to the cell surface.
Following S1 cleavage, the Notch extracellular and transmembrane-intracellular fragments form a heterodimer that is transported to the plasma membrane. This heterodimer is held together by non-covalent interactions and is sensitive to changes in calcium levels. Endocytic trafficking pathways play a role in regulating the surface levels of the Notch receptor. The processed heterodimer is then poised for ligand binding or for ligand-independent activation.
Ligand-independent activation mechanisms
In simple terms: Notch can be turned on even without its usual binding partners.
Ligand-independent Notch activity can occur through mechanisms that do not require DSL ligands. For example, cathepsin L has been shown to activate Notch1 in a ligand-independent manner, leading to endothelial senescence. In Drosophila, Kuzbanian and TACE can activate Notch independent of ligand. Cis-interactions between Notch and its ligands can block ligand-independent Notch activity, providing a regulatory layer. Ral GTPase promotes asymmetric Notch activation by repressing ligand-independent receptor activation in the Drosophila eye.
Regulation by O-glycosylation and endocytosis
In simple terms: Sugar modifications and cellular uptake processes fine-tune Notch processing.
O-glycosylation of the Notch extracellular domain significantly influences Notch processing and function, with roles in cancer. Endocytic trafficking of the Notch receptor is a key regulator of its processing and activation. These modifications and trafficking events can affect the efficiency of S1 cleavage and the subsequent presentation of Notch at the cell surface. Dysregulation of these processes can contribute to disease.
Key Genes Involved in GO:0035334 Notch receptor processing, ligand-independent
The following genes and proteins are central to Notch receptor processing, ligand-independent (GO:0035334).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Core receptor undergoing S1 cleavage and ligand-independent activation | Mutations and processing defects linked to cancer and atherosclerosis |
| NOTCH2 | Notch receptor paralog with similar processing | Studied in T-cell biology and cancer |
| NOTCH3 | Notch receptor paralog | Implicated in vascular biology and cancer |
| NOTCH4 | Notch receptor paralog | Role in breast cancer and T-cell development |
| FURIN | Protease responsible for S1 cleavage of Notch | Key enzyme for Notch maturation |
| ADAM17 (TACE) | Metalloprotease that can activate Notch independent of ligand | Ligand-independent activation in Drosophila |
| ADAM10 (Kuzbanian) | Metalloprotease involved in Notch processing | Ligand-independent Notch activation |
| PSEN1 | Gamma-secretase component for subsequent cleavages | Notch processing and Alzheimer's disease |
| PSEN2 | Gamma-secretase component | Notch processing |
| NCSTN | Gamma-secretase component | Notch processing |
| APH1 | Gamma-secretase component | Notch processing |
| PEN2 | Gamma-secretase component | Notch processing |
| CTSL | Cathepsin L, protease that activates Notch1 ligand-independently | Endothelial senescence and atherosclerosis |
| RAL | Ral GTPase represses ligand-independent Notch activation | Asymmetric Notch activation in Drosophila eye |
| LFNG | O-fucosyltransferase that modifies Notch | Regulates Notch processing and signaling |
| MFNG | O-fucosyltransferase | Notch glycosylation |
| RFNG | O-fucosyltransferase | Notch glycosylation |
| POGLUT1 | O-glucosyltransferase | Notch glycosylation and processing |
How Is Notch receptor processing, ligand-independent Regulated?
Ligand-independent Notch processing is regulated at multiple levels. Cis-interactions between Notch and its ligands can block ligand-independent Notch activity, ensuring that signaling occurs only when appropriate. Endocytic trafficking of the Notch receptor controls its availability for processing and activation. O-glycosylation of the Notch extracellular domain by enzymes such as LFNG, MFNG, RFNG, and POGLUT1 modulates Notch processing and function. Additionally, Ral GTPase represses ligand-independent receptor activation in the Drosophila eye, contributing to asymmetric Notch activation. Cathepsin L can activate Notch1 in a ligand-independent manner under certain conditions, such as in endothelial cells.
Notch receptor processing, ligand-independent and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Atherosclerosis, cancer | Endothelial cell knockout of NOTCH1 or CTSL |
| CTSL | Atherosclerosis | CTSL knockout mice or endothelial cells |
| NOTCH1 | T-cell acute lymphoblastic leukemia | T-ALL cell lines with Notch mutations |
| FURIN | Cancer, developmental disorders | Furin knockout cell models |
| LFNG | Cancer, Notch-related disorders | LFNG knockout or overexpression models |
Ligand-independent Notch processing in cancer
Dysregulated Notch processing and signaling are implicated in various cancers. O-glycosylation of Notch, which affects its processing, plays significant roles in cancer. Ligand-independent Notch activation mechanisms can contribute to tumorigenesis by providing alternative routes to activate oncogenic Notch signaling. Understanding GO:0035334 may reveal therapeutic vulnerabilities in cancers dependent on Notch.
Notch processing in atherosclerosis
Ligand-independent activation of Notch1 by cathepsin L induces CUX1/p16(INK4a)-dependent endothelial senescence associated with atherosclerosis. This highlights a direct link between GO:0035334-related processing and cardiovascular disease. Targeting ligand-independent Notch activation may offer therapeutic strategies for atherosclerosis.
Notch processing in T-cell biology
Ligand-independent Notch signaling has been reviewed in the context of T-cells, where it can influence development and function. The processing steps defined by GO:0035334 are essential for T-cell Notch activity. Further research may uncover roles in autoimmune diseases and immunodeficiencies.
From Notch receptor processing, ligand-independent-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of FURIN abolish S1 cleavage? | FURIN knockout cell line (e.g., HEK293) |
| Does a point mutation in the S1 cleavage site prevent Notch processing? | Point-mutation knock-in of NOTCH1 at the S1 site |
| Can tagged Notch be used to track processing? | Knock-in of epitope-tagged NOTCH1 |
| Does overexpression of CTSL induce ligand-independent Notch activation? | CTSL overexpression in endothelial cells |
| Does loss of Ral GTPase affect ligand-independent Notch activation? | Ral knockout or knockdown in Drosophila eye |
| Does O-glycosylation regulate Notch processing? | Knockout of LFNG, MFNG, RFNG, or POGLUT1 |
How to Study the Notch receptor processing, ligand-independent Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Notch cleavage products and heterodimer | Assessing S1 cleavage efficiency |
| Immunofluorescence | Subcellular localization of Notch | Trafficking and surface expression |
| CRISPR knockout screen | Genes required for Notch processing | Identifying novel regulators |
| RNA-seq | Transcriptional changes | Downstream effects of Notch activation |
| Proteomics | Protein interactions and modifications | Identifying Notch processing complex components |
| Flow cytometry | Cell surface Notch levels | Quantifying processed Notch at the surface |
| Luciferase reporter assay | Notch transcriptional activity | Measuring ligand-independent activation |
| Co-immunoprecipitation | Protein-protein interactions | Detecting Notch heterodimer and partners |
Biochemical analysis of Notch cleavage
Western blotting with antibodies against Notch extracellular and intracellular domains can detect the S1 cleavage products and heterodimer formation. Immunoprecipitation followed by mass spectrometry can identify interacting proteins and post-translational modifications.
Imaging of Notch trafficking
Fluorescence microscopy of tagged Notch receptors can visualize trafficking from the ER/Golgi to the cell surface and endocytic routes. Live-cell imaging can track the dynamics of Notch processing and surface presentation.
Genetic screens and CRISPR libraries
CRISPR knockout libraries can be used to identify genes required for ligand-independent Notch processing. Reporter assays for Notch activity can be combined with library screening to uncover regulators.
Transcriptomic and proteomic profiling
RNA-seq can reveal downstream transcriptional changes upon modulation of ligand-independent Notch processing. Proteomics can identify changes in Notch processing intermediates and interacting partners.
How CRISPR Can Be Used to Study GO:0035334 Notch receptor processing, ligand-independent
Knockout
CRISPR knockout of genes such as FURIN, ADAM10, ADAM17, or CTSL can abolish or reduce ligand-independent Notch processing, allowing researchers to assess their requirement. Knockout of Notch glycosyltransferases (LFNG, MFNG, RFNG, POGLUT1) can reveal their roles in processing.
Point Mutation
Introducing point mutations at the S1 cleavage site of NOTCH1 can prevent cleavage and block heterodimer formation, providing a precise tool to study the consequences of loss of ligand-independent processing. Point mutations in protease active sites can also be used.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous NOTCH1 allows real-time tracking of processing and trafficking. Knock-in of disease-associated mutations can model their effects on ligand-independent processing.
Overexpression
Overexpression of CTSL or other proteases can induce ligand-independent Notch activation, as shown in endothelial cells. Overexpression of Notch ligands can block ligand-independent activity through cis-interactions.
How EDITGENE Supports Notch receptor processing, ligand-independent Research
Researchers studying Notch receptor processing, ligand-independent-related genes often need to determine whether a candidate gene is causally involved in the processing pathway or in downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for Notch receptor processing, ligand-independent research.
Frequently Asked Questions About Notch receptor processing, ligand-independent
What is GO:0035334?
GO:0035334 is the Gene Ontology term for Notch receptor processing, ligand-independent, which describes the proteolytic cleavages of the Notch protein that occur before ligand binding, including the S1 cleavage in the secretory pathway.
What is Notch S1 cleavage?
Notch S1 cleavage is the primary proteolytic event within the Notch extracellular domain that occurs in the secretory pathway, generating a heterodimer that is transported to the cell surface.
What genes are involved in Notch receptor processing, ligand-independent?
Key genes include NOTCH1-4, FURIN, ADAM10, ADAM17, PSEN1, PSEN2, NCSTN, APH1, PEN2, CTSL, and glycosyltransferases like LFNG, MFNG, RFNG, and POGLUT1.
How is ligand-independent Notch activation different from canonical Notch signaling?
Canonical Notch signaling requires ligand binding to trigger additional cleavages, whereas ligand-independent activation occurs without DSL ligands, often through alternative proteases or processing events.
What diseases are associated with ligand-independent Notch processing?
Diseases include atherosclerosis, cancer, and T-cell-related disorders, where dysregulated Notch processing contributes to pathogenesis.
Can CRISPR be used to study Notch receptor processing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the genes and mechanisms involved in ligand-independent Notch processing.
What is the role of cathepsin L in Notch processing?
Cathepsin L can activate Notch1 in a ligand-independent manner, leading to endothelial senescence and atherosclerosis.
How does O-glycosylation affect Notch processing?
O-glycosylation of the Notch extracellular domain by enzymes such as LFNG, MFNG, RFNG, and POGLUT1 modulates Notch processing, trafficking, and signaling, with implications in cancer.
What model systems are used to study ligand-independent Notch processing?
Common models include Drosophila genetics, mammalian cell lines (e.g., HEK293, endothelial cells), and CRISPR-engineered cell lines.
What methods are used to measure Notch processing?
Methods include Western blotting, immunofluorescence, flow cytometry, luciferase reporter assays, and proteomics.
Conclusion
GO:0035334, Notch receptor processing, ligand-independent, is a fundamental biological process that governs the maturation and surface presentation of Notch receptors before ligand engagement. Its dysregulation is linked to cancer, atherosclerosis, and immune disorders, making it a critical area of research. Advances in CRISPR-based models and screening technologies continue to unravel the molecular players and regulatory mechanisms, offering new opportunities for therapeutic intervention.
References
- 1. Palmer WH et al.. 2015. Ligand-Independent Mechanisms of Notch Activity.. Trends Cell Biol 25(11):697-707 PMID: 26437585
- 2. Steinbuck MP et al.. 2018. A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells.. Front Immunol 9:1230 PMID: 29910816
- 3. Wu Y et al.. 2026. Ligand-Independent Activation of Notch1 by Cathepsin L Induces CUX1/p16(INK4a)-Dependent Endothelial Senescence Associated With Atherosclerosis.. Aging Cell 25(6):e70563 PMID: 42210653
- 4. Schnute B et al.. 2018. Endocytic Trafficking of the Notch Receptor.. Adv Exp Med Biol 1066:99-122 PMID: 30030824
- 5. Palmer WH et al.. 2014. Cis-interactions between Notch and its ligands block ligand-independent Notch activity.. Elife 3 PMID: 25486593
- 6. Delwig A et al.. 2008. Kuz and TACE can activate Notch independent of ligand.. Cell Mol Life Sci 65(14):2232-43 PMID: 18535782
- 7. Wang W et al.. 2022. Significant Roles of Notch O-Glycosylation in Cancer.. Molecules 27(6) PMID: 35335147
- 8. Cho B et al.. 2011. Ral GTPase promotes asymmetric Notch activation in the Drosophila eye in response to Frizzled/PCP signaling by repressing ligand-independent receptor activation.. Development 138(7):1349-59 PMID: 21350007
